Treatable risk factors included anemia in 40% of patients, and elevated total plasma homocysteine or homozygosity for the t-MTHFR mutation in 21%.

 
  • 可治療的風(fēng)險因子包括40%25病患有貧血癥,21%25的人血漿中同型半胱氨酸升高或有t-MTHFR突變的同質(zhì)性。
今日熱詞
目錄 附錄 查詞歷史
国内精品美女A∨在线播放xuan